ephedrine has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogun, B; Craig, J; Larsen, A; Marr, B; Mayo, E; McKinnel, M; Russell, M; Watson, J | 1 |
| Han, Y; Kong, L; Liu, C; Ren, J; Sun, H; Tang, S; Wang, XJ; Yan, G | 1 |
| Higashiura, A; Ito, M; Kakimoto, M; Mikage, M; Nazmul, T; Nomura, T; Ogawa, KO; Ohge, H; Sakaguchi, T; Sasaki, H; Yamamoto, A | 1 |
1 review(s) available for ephedrine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Ephedrae Herba: A Review of Its Phytochemistry, Pharmacology, Clinical Application, and Alkaloid Toxicity.
Topics: Alkaloids; Antineoplastic Agents; COVID-19; Drugs, Chinese Herbal; Ephedra; Ephedrine; Humans | 2023 |
2 other study(ies) available for ephedrine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Trends of clandestine laboratories manufacturing methamphetamine in New Zealand between 2009-2021: Evolution, enforcement, legislative, and COVID-19 effects.
Topics: COVID-19; Ephedrine; Humans; Laboratories; Methamphetamine; New Zealand; Pandemics; Pseudoephedrine | 2023 |
In vitro anti-severe acute respiratory syndrome coronavirus 2 effect of Ephedra przewalskii Stapf extract.
Topics: Alkaloids; Antiviral Agents; COVID-19; Ephedra; Ephedra sinica; Ephedrine; Plant Extracts; SARS-CoV-2 | 2024 |